287 related articles for article (PubMed ID: 25572472)
1. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
[TBL] [Abstract][Full Text] [Related]
2. Bacillus anthracis inosine 5'-monophosphate dehydrogenase in action: the first bacterial series of structures of phosphate ion-, substrate-, and product-bound complexes.
Makowska-Grzyska M; Kim Y; Wu R; Wilton R; Gollapalli DR; Wang XK; Zhang R; Jedrzejczak R; Mack JC; Maltseva N; Mulligan R; Binkowski TA; Gornicki P; Kuhn ML; Anderson WF; Hedstrom L; Joachimiak A
Biochemistry; 2012 Aug; 51(31):6148-63. PubMed ID: 22788966
[TBL] [Abstract][Full Text] [Related]
3. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
Digits JA; Hedstrom L
Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis.
Gan L; Petsko GA; Hedstrom L
Biochemistry; 2002 Nov; 41(44):13309-17. PubMed ID: 12403633
[TBL] [Abstract][Full Text] [Related]
5. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Inosine-5'-monophosphate Dehydrogenase from Bacillus anthracis: Mechanism Revealed by Pre-Steady-State Kinetics.
Wei Y; Kuzmič P; Yu R; Modi G; Hedstrom L
Biochemistry; 2016 Sep; 55(37):5279-88. PubMed ID: 27541177
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site.
Prosise GL; Wu JZ; Luecke H
J Biol Chem; 2002 Dec; 277(52):50654-9. PubMed ID: 12235158
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
[TBL] [Abstract][Full Text] [Related]
9. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.
Hedstrom L; Liechti G; Goldberg JB; Gollapalli DR
Curr Med Chem; 2011; 18(13):1909-18. PubMed ID: 21517780
[TBL] [Abstract][Full Text] [Related]
10. IMP dehydrogenase: the dynamics of drug selectivity.
Hedstrom L; Gan L; Schlippe YG; Riera T; Seyedsayamdost M
Nucleic Acids Res Suppl; 2003; (3):97-8. PubMed ID: 14510398
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism.
Prosise GL; Luecke H
J Mol Biol; 2003 Feb; 326(2):517-27. PubMed ID: 12559919
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism.
Hedstrom L; Wang CC
Biochemistry; 1990 Jan; 29(4):849-54. PubMed ID: 1971185
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds.
Makowska-Grzyska M; Kim Y; Gorla SK; Wei Y; Mandapati K; Zhang M; Maltseva N; Modi G; Boshoff HI; Gu M; Aldrich C; Cuny GD; Hedstrom L; Joachimiak A
PLoS One; 2015; 10(10):e0138976. PubMed ID: 26440283
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
15. IMP dehydrogenase : structural aspects of inhibitor binding.
Goldstein BM; Colby TD
Curr Med Chem; 1999 Jul; 6(7):519-36. PubMed ID: 10390598
[TBL] [Abstract][Full Text] [Related]
16. Structure of Pseudomonas aeruginosa inosine 5'-monophosphate dehydrogenase.
Rao VA; Shepherd SM; Owen R; Hunter WN
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Mar; 69(Pt 3):243-7. PubMed ID: 23519796
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Lee S; Ku AF; Vippila MR; Wang Y; Zhang M; Wang X; Hedstrom L; Cuny GD
Bioorg Med Chem Lett; 2020 Dec; 30(24):127543. PubMed ID: 32931912
[TBL] [Abstract][Full Text] [Related]
18. Covalent inactivation of Mycobacterium thermoresistibile inosine-5'-monophosphate dehydrogenase (IMPDH).
Trapero A; Pacitto A; Chan DS; Abell C; Blundell TL; Ascher DB; Coyne AG
Bioorg Med Chem Lett; 2020 Jan; 30(2):126792. PubMed ID: 31757668
[TBL] [Abstract][Full Text] [Related]
19. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
Shu Q; Nair V
Med Res Rev; 2008 Mar; 28(2):219-32. PubMed ID: 17480004
[TBL] [Abstract][Full Text] [Related]
20. Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction.
Guillén Schlippe YV; Riera TV; Seyedsayamdost MR; Hedstrom L
Biochemistry; 2004 Apr; 43(15):4511-21. PubMed ID: 15078097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
